SCA
MED icon

Snowden Capital Advisors’s Medifast MED Stock Holding History

Snowden Capital Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,022
Closed -$364K – 1148
2022
Q2 		$364K Buy
2,022
+237
+13% +$42.4K 0.02% 778
2022
Q1 		$304K Buy
+1,785
New +$337K 0.01% 814

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Snowden Capital Advisors's MED Position: Q3 2022 in Review

Snowden Capital Advisors sold out of Medifast (MED) in Q3 2022, closing a stake of 2,022 shares — an estimated $364K sold.

Snowden Capital Advisors first reported a position in MED in Q1 2022 and held it in 2 quarters. The position peaked at $364K in Q2 2022. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Snowden Capital Advisors reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 2,022 Medifast shares in Q3 2022, an estimated $364K.
  • Snowden Capital Advisors first reported a position in Medifast in Q1 2022 and held it in 2 quarters.
  • Snowden Capital Advisors's Medifast position peaked at $364K in Q2 2022.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Snowden Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.